Advancing treatments for rare diseases together

Andrew Slade

Andrew Slade has a PhD in biochemistry and a post-graduate diploma in clinical research. He has more than 30 years of nonclinical, early phase clinical and CMC experience in both biologics and small molecules, across multiple therapeutic areas, gained in biotech and large pharma settings

At EspeRare, Andrew provides general scientific and medical writing support.

Andrew Slade
Senior Clinical Development Scientist